DP303c in Patients With HER2-positive Advanced Breast Cancer
DP303c in Patients With HER2-positive Advanced Breast Cancer
Not yet recruiting · NCT05901935 · Registry updated 2023-06-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| DP303c in Patients With HER2-positive Advanced Breast Cancer | HER2-positive Advanced Breast Cancer | Not yet recruiting | Phase 3 | 2023-06-13 | NCT05901935 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 39 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||